Augmento Xray - A US FDA Cleared Chest X Ray Reporting solution

Reduce Chest X Ray reporting workload by 30-50%

Features Highlights

Augmento XRay - AI based triaging for CXRs
AI Triaging

Classification of scans with and without suspicions at high precision

Smart Reporting

Productivity gain in reporting scans with "high suspicion"

Driving the Future of Radiology with

 Responsible AI

C. Responsible AI

Build Trust, Measure RoI on AI, Enable Feedback

Cost Saving and productivity gain

Cost impact of automating normal scan reporting

Parameter Description Hospital A Hospital B Hospital C Hospital D
Precision (Normal) Out of all the cases predicted by Al as Normal, what percentage of them are actually Normal 99% 97% 97% 96%
False Discovery Rate(FDR) Out of all cases segregated by Al as normal, what percentage of them are actually abnormal 1% 3% 3% 4%
Reduction in workload Percentage of all scans that can be reported as normal by Al 63% 55% 37% 45%
Error rate (in clinical settings) Out of all scans predicted by radiologist as normal, what percentage of them were actually abnormal 8% 6% 8% 11%
Abstract : Segregation of normal chest radiographs from abnormal chest radiographs using DeepTek AI: retrospective and prospective analyses - presented at RSNA 2023

Presented at RSNA 2023 : Segregation of normal chest radiographs from abnormal chest radiographs using DeepTek AI: retrospective and prospective analyses.
By Pant, R., Gupte, T., Varma, S., Kulkarni, V., & Kharat, A.

Regulatory Approvals

US FDA Cleared

CDSCO Approved

Kenya Board Certified

Thai FDA Approved

Malayasia Board Approval

Our Research

Abstract Presentation at SGCR WIRES in Singapore

SGCR WIRES 2022 - A clinical evaluation study employing a deep learning approach to calculate cardiothoracic ratio from chest radiographs

Abstract Presentation at AOCR and KCR - Deep learning-based Automatic Detection of Pulmonary Nodules on Chest Radiographs

AOCR & KCR 2022 - Deep learning-based Automatic Detection of Pulmonary Nodules on Chest Radiographs

Presentation of TB Screening solution at The Union Lung Health Conference

Evaluation study presented by FIT at The Union 2022 - The study reported that each CAD software (total 3 evaluated including Genki v2) performed similarly and achieved less than 5% loss of TB yields.

Impact Stories

Genki leveraged at Greater Chennai Corporation for TB screening

Augmento becomes National AI platform for Singapore - adopted by Synapxe

Transforming radiology worklow at Maxicare Healthcare - Phillipines